A round of Series A financing involving Fresenius Medical Care Ventures and other investors brought in $2.9 million for medtech imaging developer Modulated Imaging. The proceeds will be used to develop a next-generation version of the Ox-Imager CS system, as well as for the expansion of clinical studies.
A $190 million all-cash deal was reached by LivaNova to sell its cardiac rhythm management business to MicroPort Scientific, its partner in a cardiac rhythm management joint venture in China. The sale, which is expected to be completed in the second quarter of 2018, will allow LivaNova to concentrate on its neuromodulation and cardiac surgery businesses, company CEO Damien McDonald said.
European regulators gave specialist medical imaging group Feedback CE mark approval for its TexRAD Lung technology, software that analyzes texture features in CT scans for use in the diagnosis and treatment of lung cancer.
A five-year exclusive deal was reached by MDxHealth with pharmaceutical firm Ferrer for Ferrer to sell MDxHealth's SelectMDx for Prostate Cancer test to 1,000 urologists in Spain. The agreement, for which additional terms were not disclosed, will be implemented in January.
A strategic alliance agreement was signed by Florida-based medtech company NeuX Technologies and GoX Studio to combine NeuX's Interactive Neuromuscular Stimulation technology platform with GoX's SmartWork platform. The partnership aims to improve chronic pain and musculoskeletal injury diagnosis, treatment, prevention, monitoring and measurement.
WebMD, as part of its growing artificial-intelligence effort and partnership with Reckitt Benckiser, has introduced a chatbot for the Mucinex character Mr. Mucus. People looking up cold and flu symptoms will be prompted by the chatbot on WebMD to ask questions about symptoms and view Mucinex-branded advice on cough and congestion treatments.
In a study in the journal Hepatology, researchers from University of Texas Health found that treatment with the drugs glecaprevir and pibrentasvir resulted in high rates of sustained virologic response in hepatitis C patients with genotypes 1 and 4 who did not respond to other direct-acting antivirals.
A joint team of investigators is studying how and where a malaria vaccine can be stabilized to create a stronger vaccine. The research seeks to gain an improved understanding of how the human immune system identifies malaria parasites using the RTS,S vaccine.
Days after the FDA granted approval for Genentech's hemophilia A candidate emicizumab, or Hemlibra, the company announced results from the HAVEN 3 study that showed the drug was linked with a significant decline in the rate of treated bleeds for patients treated weekly.
Although serum endomysial antibodies and antibodies to tissue transglutaminase tests are useful in screening for celiac disease in patients still eating gluten, the tests have low sensitivity for those with biopsy-confirmed celiac disease who are on gluten-free diets, a meta-analysis shows. "In the absence of a non-invasive biomarker, follow-up duodenal biopsy remains the only appropriate test to assess mucosal recovery in children and adults with celiac disease," researchers said.